TargetMol

Olesoxime

Product Code:
 
TAR-T7629
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T7629-2mg2mg£99.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7629-5mg5mg£116.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7629-1mL1 mL * 10 mM (in DMSO)£121.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7629-10mg10mg£140.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7629-25mg25mg£211.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7629-50mg50mg£319.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T7629-100mg100mg£444.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Olesoxime (TRO19622), A Mitochondrial-Targeted Neuroprotective Compound,is an experimental neuroprotective drug.
CAS:
22033-87-0
Formula:
C27H45NO
Molecular Weight:
399.663
Pathway:
Metabolism
Purity:
0.98
SMILES:
CC(C)CCCC(C)C1CCC2C3CCC4=CC(CCC4(C)C3CCC12C)=NO
Target:
Mitochondrial Metabolism

References

Thierry B , Patrick B , Jean-Louis A , et al. Olesoxime (TRO19622): A Novel Mitochondrial-Targeted Neuroprotective Compound[J]. Pharmaceuticals, 2010, 3(2):345-368. Magalon K , Le Grand M , El Waly B , et al. Olesoxime favors oligodendrocyte differentiation through a functional interplay between mitochondria and microtubules[J]. Neuropharmacology, 2016:S0028390816303847.